Purpose: Medication errors reported to FDA as adverse events in which methotrexate was identified as a possible contributor were studied. Methods: All adverse-event reports submitted to FDA ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Low-dose methotrexate was not clinically effective for lowering blood pressure among patients without rheumatic disease who have cardiovascular risk factors.

Nearly 40% of pregnancy-capable patients with rheumatic disease are unaware of the potential impacts of their medications on ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Recently, Cardinal Antonio Canizares Llovera, prefect for the Vatican’s Congregation for Divine Worship and the Discipline of the Sacraments, encouraged Catholics to consider receiving holy ...

In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.